Precision Bio Says USPTO Rejects Claims in Cellectis Patents

The US Patent Office's decision is the latest development in an ongoing IP dispute between the firms that involves several related patents.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.